These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 36538720)

  • 21. Bowel Functional Outcomes After Long-Course or Short-Course Radiation for Advanced Rectal Cancers: A Propensity-Matched Analysis.
    Kazi M; Jajoo B; Kapadia R; Dohale S; Bhuta P; Desouza A; Saklani A
    Dis Colon Rectum; 2022 Dec; 65(12):1494-1502. PubMed ID: 36382840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
    Garoufalia Z; Freund MR; Gefen R; Meyer R; DaSilva G; Weiss EG; Wexner SD
    Dis Colon Rectum; 2023 Jul; 66(7):898-904. PubMed ID: 36649177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
    Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
    Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy.
    Kohrman NM; Wlodarczyk JR; Ding L; McAndrew NP; Algaze SD; Cologne KG; Lee SW; Koller SE
    Dis Colon Rectum; 2024 Jul; 67(7):920-928. PubMed ID: 38498775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
    Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
    Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiologic Factors and Areas of Local Recurrence in Locally Advanced Lower Rectal Cancer After Lateral Pelvic Lymph Node Dissection.
    Shiraishi T; Sasaki T; Tsukada Y; Ikeda K; Nishizawa Y; Ito M
    Dis Colon Rectum; 2021 Dec; 64(12):1479-1487. PubMed ID: 34657076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced Lymph Node Staging With Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision for Rectal Cancer: A Retrospective Cohort Study.
    Widmann B; Almarie B; Warschkow R; Beutner U; Weitzendorfer M; Schmid MB; Ukegjini K; Brunner W
    Dis Colon Rectum; 2022 Aug; 65(8):1015-1024. PubMed ID: 34856584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Outcomes of Minimally Invasive Versus Open Abdominoperineal Resection for Rectal Cancer: A Single Specialized Center Experience.
    Segev L; Schtrechman G; Kalady MF; Liska D; Gorgun IE; Valente MA; Nissan A; Steele SR
    Dis Colon Rectum; 2022 Mar; 65(3):361-372. PubMed ID: 34784318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
    Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
    Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
    Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
    Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
    Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Propensity Score-Matched Analysis of the Impact of Neoadjuvant Radiation Therapy on the Outcomes of Stage II and III Mucinous Rectal Carcinoma.
    Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Wexner SD
    Dis Colon Rectum; 2024 May; 67(5):655-663. PubMed ID: 38231014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI at Restaging After Neoadjuvant Therapy for Rectal Cancer Overestimates Circumferential Resection Margin Proximity as Determined by Comparison With Whole-Mount Pathology.
    Yuval JB; Thompson HM; Firat C; Verheij FS; Widmar M; Wei IH; Pappou E; Smith JJ; Weiser MR; Paty PB; Nash GM; Shia J; Gollub MJ; Garcia-Aguilar J
    Dis Colon Rectum; 2022 Apr; 65(4):489-496. PubMed ID: 34803147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term Outcomes of Elective Surgery Following Self-Expandable Metallic Stent and Neoadjuvant Chemotherapy in Patients With Left-Sided Colon Cancer Obstruction.
    Han JG; Wang ZJ; Dai Y; Li XR; Qian Q; Wang GY; Zhai ZW; Zeng WG
    Dis Colon Rectum; 2023 Oct; 66(10):1319-1328. PubMed ID: 35671281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
    Sakamoto Y; Morohashi H; Miura T; Tsutsumi S; Takahashi S; Hirama K; Wakiya T; Hakamada K
    Dis Colon Rectum; 2022 May; 65(5):663-671. PubMed ID: 33833145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent High Rate of Positive Margins and Postoperative Complications After Surgery for cT4 Rectal Cancer at a National Level.
    de Nes LCF; Drager LD; Verstegen MG; Burger JWA; Tanis PJ; de Wilt JHW;
    Dis Colon Rectum; 2021 Apr; 64(4):389-398. PubMed ID: 33651005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
    Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the Validity of the Clavien-Dindo Classification in Colectomy Studies: A 90-Day Cost of Care Analysis.
    Widmar M; Keskin M; Strombom PD; Gennarelli RL; Szeglin BC; Smith JJ; Nash GM; Weiser MR; Paty PB; Russell D; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Nov; 64(11):1426-1434. PubMed ID: 34623350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
    Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
    Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.